iOS app Android app

Biologic Drugs

Why USTR Should Not Put MPAA and PhRMA Ahead of Other Industries (and Consumers) in Trade Negotiations, including TPP

James Love | Posted 02.08.2014 | Politics
James Love

This week in Singapore, the Obama administration has a different focus -- providing "more" for the MPAA and big pharma lobby. That should change, before this huge trade deal is concluded.

Taking Care of Business (Interests), It's a Bipartisan Cause

James Love | Posted 11.06.2012 | Politics
James Love

2012-08-28-scblog2.pngWhile the GOP and Democratic conventions highlight the differences between the parties, there are some bipartisan issues -- and one of the biggest is taking care of corporate interests.

Biologic Drugs May Be Cheaper, But Are They Safe?

John Horton | Posted 05.25.2011 | Home
John Horton

Biologics are an exciting new world of medicine. But the EMA's new guidelines should put patient safety first by requiring biosimilars to be held to the same safety and standards as the original drug.

Are Unsafes Drugs An 'Acceptable Risk?' FDA Should Say 'No!'

John Horton | Posted 05.25.2011 | Home
John Horton

As a matter of common sense, the FDA's process for biosimilars shouldn't sacrifice patient safety.

House Health Care Bill: A Death Sentence For My Fellow Breast Cancer Survivors

Jane Hamsher | Posted 05.25.2011 | Politics
Jane Hamsher

Pelosi made a choice about the lifesaving biologic drugs I took when I was in chemotherapy that will cost many fellow breast cancer survivors everything they own, and quite possibly their lives.